Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Testing effectiveness (Phase 2)Looking for participantsNCT07641036
What this trial is testing

Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+2 more
Beijing Biotech 30
Early research (Phase 1)Ended earlyNCT01949870
What this trial is testing

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Who this might be right for
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
AstraZeneca 6
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Testing effectiveness (Phase 2)Looking for participantsNCT07506057
What this trial is testing

Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy

Who this might be right for
Urothelial CarcinomaBiliary Tract CancerHER2
Xiujuan Qu 20
Testing effectiveness (Phase 2)Study completedNCT00661830
What this trial is testing

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

Who this might be right for
Adenocarcinoma
PD Dr Markus Möhler 103
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Study completedNCT04838964
What this trial is testing

MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Advanced or Metastatic Biliary Tract Cancer
Lepu Biopharma Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Testing effectiveness (Phase 2)Looking for participantsNCT07146646
What this trial is testing

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerBiliary Tract NeoplasmsCholangiocarcinoma+2 more
Case Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04910386
What this trial is testing

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Who this might be right for
Biliary Tract Neoplasms
3D Medicines (Sichuan) Co., Ltd. 126
Large-scale testing (Phase 3)UnknownNCT03873532
What this trial is testing

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Who this might be right for
Biliary Tract Cancer
Hutchison Medipharma Limited 298
Testing effectiveness (Phase 2)Study completedNCT05074472
What this trial is testing

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more
ZielBio, Inc. 35
Early research (Phase 1)Ended earlyNCT01282333
What this trial is testing

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+11 more
National Cancer Institute (NCI) 44
Large-scale testing (Phase 3)Study completedNCT01149122
What this trial is testing

Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

Who this might be right for
Unresectable, Metastatic Biliary Tract Carcinoma
Samsung Medical Center 266
Testing effectiveness (Phase 2)Looking for participantsNCT05523947
What this trial is testing

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Who this might be right for
HER2-Positive Solid Tumor
Yuhan Corporation 147
Not applicableNot Yet RecruitingNCT06463548
What this trial is testing

Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Yunpeng Liu 30
Early research (Phase 1)Looking for participantsNCT07107750
What this trial is testing

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract CancerMetastatic Biliary Tract Carcinoma
Washington University School of Medicine 48
Next Page